Both in Pharmaceuticals
Arcutis Biotherapeutics vs Parabilis Medicines
Over the past year ARQT returned +34.0% and PBLS returned −20.7%; their daily moves had a correlation of 0.35.
ARQT +34.0% PBLS −20.7%Growth of $1, one year, split-adjusted
| Metric | ARQT | PBLS |
|---|---|---|
| Price | $32.00 | $29.25 |
| Market cap | $4.02B | $3.61B |
| Today | +2.37% | +7.34% |
| 1 month | +27.2% | −0.9% |
| 6 months | +36.6% | — |
| Year to date | +10.2% | — |
| 1 year | +26.4% | — |
| Revenue growth (YoY) | +59.3% | — |
| Gross margin | 91.6% | 100.0% |
| Net margin | 11.6% | −45239.9% |
| P/E (TTM) | 141.0× | — |
| Price / sales | 8.7× | — |
| Net cash | $129.7M | $1.11B |
| Dividend yield | — | — |
| Volatility (60d) | 53.5% | — |
| Short % of float | 18.0% | 9.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).